| Literature DB >> 34778775 |
Ronel Müller1, Tiaan M Gerwel2, Magambo Phillip Kimuda3, Özlem Tastan Bishop3, Clinton G L Veale1, Heinrich C Hoppe4.
Abstract
HPPK, which directly precedes DHPS in the folate biosynthetic pathway, is a promising but chronically under-exploited anti-microbial target. Here we report the identification of new S. enterica HPPK inhibitors, offering potential for new resistance circumventing S. enterica therapies as well as avenues for diversifying the current HPPK inhibitor space. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 34778775 PMCID: PMC8528203 DOI: 10.1039/d1md00237f
Source DB: PubMed Journal: RSC Med Chem ISSN: 2632-8682